Ethanol embolization of vascular malformations.

Yakes, Wayne F.; Luethke, James M.; Parker, Steve H.; Stavros, A. Thomas; Rak, Kevin M.; Hopper, Kenneth D.; Dreisbach, James N.; Griffin, David J.; Seibert, Charles E.; Carter, T E

doi:10.1148/radiographics.10.5.2217971

Cited by 161 publications

(94 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among these agents, ethanol is the most widely used, since it is cheap, easily available, and potent. Ethanol produces denudation of the endothelium, a severe inflammatory reaction, and thrombosis of the venous malformation (3,16). Ethanol is reported to be the most reliable substance among all sclerosing agents and to have the lowest recurrence rate (11,17).…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx

Akan¹,

Uzunkaya²,

Soylu³

2017

Erciyes Med J

View full text Add to dashboard Cite

Objective: Percutaneous ethanol sclerotherapy has shown to be efficient in treating venous malformations of the head and neck. Our aim was to assess the safety and efficacy of percutaneous ethanol sclerotherapy in treating venous malformations of the oral cavity and the oropharynx. Materials and Methods:From 2007 to 2015, 57 percutaneous procedures using ethanol were performed in 13 patients. Medical records of these patients were retrospectively analyzed. One patient was male and 12 were females. The patients' age ranged from 8 to 65 years (mean age, 30 years). The mean follow-up was 11 months. The volume of ethanol used per session ranged from 0.4 to 14 mL (mean volume, 6 mL) in 12 patients, except the syndromic patient.Results: In 7 out of 13 patients (53.4%), the lesions were resolved completely. In 3 patients (23%), sclerotherapy alleviated the symptoms. In 2 patients (15.3%), the lesions did not sufficiently respond to the therapy. In 1 patient (7.6%), sclerotherapy failed due to misdiagnosis. No major complications were encountered. All the patients experienced pain to a tolerable degree. Swelling, induration, and darkening of the lesion occurred following injections. In 1 patient, ulceration and cleavage on the tongue was resolved within 15 days after emergence. Conclusion:Percutaneous ethanol sclerotherapy is a reliable and efficacious method of treating venous malformations of the oral cavity and oropharynx.

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx

Akan¹,

Uzunkaya²,

Soylu³

2017

Erciyes Med J

View full text Add to dashboard Cite

show abstract

“…Potential explanations for temporary response are that vascular damage is reversible or incomplete. Some authors have cited recanalization and neovascular recruitment as cause for increasing symptoms and suggest serial injections for maximal results [7,9,17]. If the presence of a mass is concerning to the patient and marginal excision can be achieved without sacrificing function, surgical excision then may be warranted, with a reported recurrence rate less than 10% [1,3,13].…”

Section: Discussionmentioning

confidence: 99%

“…Surgeons often resort to performing intralesional excision rather than compromise muscle and nerve function for a benign condition; one large retrospective series reported an intralesional excision rate of 62% [1], and a smaller series reported a 30% rate of intralesional excision [3]. However, the rate of recurrence after incomplete excision is reportedly as much as 18% to 50% [1,4,15] and tumor remnants can grow aggressively, causing symptoms even worse than before surgery [17]. If complete excision can be achieved, the recurrence rate is reportedly as low as 0% to 9% [1,3,13], but complications such as fibrosis and muscle weakness are common after surgery [7].…”

Section: Introductionmentioning

confidence: 99%

“…Currently, reports generally comprise deep and superficial lesions, often include those of the face and skull and intrapelvic lesions, or investigate the use of alternate sclerosing agents [6,8,9,[14][15][16][17]. There also is a paucity of literature concerning the utility of sclerotherapy as an analgesic treatment modality in these lesions, as numerous reports address cosmetic issues, spinal cord compression, or, in the case of massive lesions, cardiovascular compromise [6,8,16,17].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Ethanol Sclerotherapy Reduces Pain in Symptomatic Musculoskeletal Hemangiomas

Crawford

Slotcavage

King

et al. 2009

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Hemangiomas, benign vascular lesions, require intervention if causing pain or functional limitations. Functional deficits are common after excision, favoring minimally invasive treatments. To determine whether ethanol sclerotherapy reduces pain and lesion size and to assess complications in symptomatic musculoskeletal hemangiomas, we retrospectively reviewed 19 patients (six males, 13 females; mean age, 34 years) meeting criteria of confirmed hemangioma, treatment with ethanol sclerotherapy, and minimum of 6 weeks of followup. Fourteen were primary lesions and five were recurrent; all were painful. Thirty-eight sclerotherapy procedures were performed, with each patient undergoing a maximum of three procedures. Mean followup was 24 months (range, 2-95 months). Four patients reported full pain relief, 11 had partial relief, and four had no relief. With recurrent lesions, one patient had full pain relief, one had partial relief, and three had no relief. For patients with lesions larger than 5 cm, two had full relief, six had partial relief, and three had no relief. Lesion shrinkage occurred in 12 patients.

show abstract

“…Endovascular embolization prior to microsurgery is largely used when treating large AVM lesions [22][23][24][25][26]. Such a procedure has numerous advantages such as reduced blood loss, shorter surgical times, increased ability to occlude vessels difficult to control, and the benefit of staging flow reduction in the nidus [13,18].…”

Section: Presurgical Embolizationmentioning

confidence: 99%

Endovascular Management of Cerebral Arteriovenous Malformations in Pregnancy: Two Case Reports and a Review of the Literature

Agarwal

2012

J Neurol Res

View full text Add to dashboard Cite

Cerebral arteriovenous malformations are rare, congenital lesions that affect the vasculature of the brain and have the possibility of rupturing. The presentation of a cerebral arteriovenous malformations in a pregnant woman warrants an even greater level of concern due to the maternal physiological changes, which may affect the structural integrity of the arteriovenous malformations and lead to hemorrhaging. A proper plan of action should be deployed to successfully treat pregnant women with cerebral arteriovenous malformations. In all cases, both the mother's and fetus's well being must be taken into consideration. Two cases and the current management options for cerebral arteriovenous malformations in pregnancy are presented. Online databases, such as PubMed provided by the United States National Library of Medicine at the National Institutes of Health, were searched for references to convey endovascular management options for cerebral arteriovenous malformations in pregnancy. Additional references were obtained from articles that were reviewed by the authors. The first case is of a 27-year-old pregnant woman with a right-sided periventricular intraparenchymal hemorrhage. She was treated with an external ventriculostomy drain. The second case is of a 26-year-old pregnant woman with a prior stage 2 embolization of a left parietal arteriovenous malformation. She did not show evidence of intracranial hemorrhage and was treated with further embolization regimens. A multifaceted approach, tailored to the individual patient may be necessary for cerebral arteriovenous malformations in pregnancy. Successful therapeutic strategies often involve close collaboration with a group of obstetricians, neuroradiologists, anesthesiologists, and neurosurgeons.

show abstract

Ethanol embolization of vascular malformations.

Cited by 161 publications

References 0 publications

Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx

Percutaneous Ethanol Sclerotherapy of Venous Malformations of the Oral Cavity and the Oropharynx

Ethanol Sclerotherapy Reduces Pain in Symptomatic Musculoskeletal Hemangiomas

Endovascular Management of Cerebral Arteriovenous Malformations in Pregnancy: Two Case Reports and a Review of the Literature

Contact Info

Product

Resources

About